STEVEN REYNO: Open Payments
NPI 1770160814 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,074 in 75 payments from 14 companies in 2025. Trend: 2023 $475 · 2024 $941 · 2025 $2,074
Food & beverage: $2,074
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 13 | $354 |
| ABBVIE INC. | 14 | $321 |
| Janssen Biotech, Inc. | 9 | $305 |
| Lilly USA, LLC | 5 | $215 |
| Regeneron Healthcare Solutions, Inc. | 6 | $207 |
| GENZYME CORPORATION | 6 | $173 |
| PFIZER INC. | 5 | $120 |
| Ardelyx, Inc. | 4 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $81 |
| Aimmune Therapeutics, Inc. | 3 | $56 |
Products named: DUPIXENT, REZDIFFRA, TREMFYA, RINVOQ, CREON, IBSRELA, OMVOH, ENTYVIO.
Industry payments across FL — which companies pay providers there.
